MFDS — authorised 29 June 1998
- Marketing authorisation holder: MERCK
- Status: likely_approved
🇰🇷 Maxalt in South Korea
MFDS authorised Maxalt on 29 June 1998
Marketing authorisation
Maxalt in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Neuroscience approved in South Korea
Frequently asked questions
Is Maxalt approved in South Korea?
Yes. MFDS authorised it on 29 June 1998.
Who is the marketing authorisation holder for Maxalt in South Korea?
MERCK holds the South Korean marketing authorisation.